nevirapine has been researched along with Neoplasms in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moghadam, NH | 1 |
| Salehzadeh, S | 1 |
| Rakhtshah, J | 1 |
| Tanzadehpanah, H | 1 |
| Moghadam, AH | 1 |
| Hajibabaei, F | 1 |
| Sharifinia, S | 1 |
| Asl, SS | 1 |
| Saidijam, M | 1 |
1 other study available for nevirapine and Neoplasms
| Article | Year |
|---|---|
Improving antiproliferative effect of the nevirapine on Hela cells by loading onto chitosan coated magnetic nanoparticles as a fully biocompatible nano drug carrier.
Topics: Antineoplastic Agents; Cell Proliferation; Chitosan; Coated Materials, Biocompatible; Drug Carriers; | 2018 |